Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to use the host protein angiotensin-converting enzyme 2 as a co-receptor to gain intracellular entry into different organs, including the heart. Cardiac involvement is one of the clinical manifestations of coronavirus disease 2019 (COVID-19) and is associated with a worse prognosis; in this setting, few cases of myo-pericarditis with complete imaging documentation have been reported. We discuss a case of a woman admitted to the emergency department with dyspnea. Nasopharyngeal swab showed positive results for SARS-CoV-2. A subsequent 12-lead electrocardiogram showed modifications of T-wave in leads V1 to V6 while blood tests revealed increased levels of troponin I. Coronary computed tomography angiography was performed, excluding hemodynamically significant coronary stenosis. Cardiac magnetic resonance (CMR) was also performed, showing findings fulfilling Lake Louise criteria for the diagnosis of acute myo-pericarditis. To date, myocardial inflammation was recognized as connected with COVID-19 mortality. CMR is an indispensable tool for non-invasive diagnosis of this pathology; however, most clinical studies demonstrated the presence of intramyocardial edema using T1 and T2 mapping sequences. In our case, extensive intramyocardial edema was well demonstrated using TIRM sequences, with a short TI to obtain fat suppression. .